Purification of Testis-Stimulating Factor in Precocious Puberty
NCT00004344 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4
Last updated 2005-06-24
Summary
OBJECTIVES:
Purify and characterize a testis-stimulating factor in the blood of adult volunteers who had precocious puberty as boys.
Conditions
- Precocious Puberty
Interventions
- DRUG
-
leuprolide
- DRUG
-
testosterone
Sponsors & Collaborators
-
Oregon Health and Science University
collaborator OTHER -
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Barry Albertson · Oregon Health and Science University
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-01-31
More Related Trials
-
Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
NCT00431197 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents
NCT03864913 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
NCT00635817 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Evaluation of Testosterone Gel (1%)
NCT00193700 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
NCT00161421 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Androgens in Man-4: (Short Title: Oral T-4)
NCT00399165 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males
NCT03541395 ·Status: COMPLETED ·Phase: NA
-
Leuprolide in Determining the Cause of Gonadotropin Deficiency
NCT00004426 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Pharmacokinetics and Safety of Testosterone
NCT01370369 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
NCT01403116 ·Status: COMPLETED ·Phase: PHASE3
-
The Adrenal Contribution to Androgen Production in Girls During Puberty
NCT01062568 ·Status: COMPLETED ·Phase: PHASE3
-
TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY
NCT03325647 ·Status: COMPLETED ·Phase: PHASE4
-
Generation of Positive Biological Samples to Leuprolide Acetate for Doping Control
NCT02920359 ·Status: COMPLETED ·Phase: PHASE1
-
Testosterone Gel Applied to Women With Pituitary Gland Problems
NCT00144391 ·Status: COMPLETED ·Phase: PHASE4
-
Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism
NCT00193661 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
NCT02149264 ·Status: COMPLETED ·Phase: PHASE3
-
Oral T7 Oral Testosterone in Man
NCT00842751 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel
NCT01703741 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Boys With Precocious Puberty
NCT00001202 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone Secretion in Transgender Males
NCT04321551 ·Status: WITHDRAWN ·Phase: PHASE4
-
ORAL T-6: Oral Androgens in Man-6
NCT00663793 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men
NCT02754687 ·Status: COMPLETED ·Phase: PHASE1
-
Phlebotomy Study of Testosterone Undecanoate
NCT02670343 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Influence of Administration Route of Testosterone on Male Fertility
NCT00705796 ·Status: WITHDRAWN ·Phase: PHASE1
-
Evaluation of Testosterone Nasal Gel in Hypogonadal Boys
NCT03345797 ·Status: TERMINATED ·Phase: PHASE1